寵物疫苗市場報告：趨勢、預測和競爭分析（至 2031 年）

全球寵物疫苗市場前景光明，在狗、貓和兔子等領域都存在應用機會。預計到 2031 年全球寵物疫苗市場規模將達到 112 億美元，2025 年至 2031 年的複合年成長率為 6.1%。市場的主要驅動力是寵物數量的增加、飼主對寵物預防性醫療保健益處的認知不斷提高以及政府對疫苗接種的監管。

• Lucintel 預測，由於伴同性動物越來越受歡迎、人們對動物健康重要性的認知不斷提高以及寵物飼主生活方式的不斷改變，犬類將繼續成為疫苗接種類別中最大的佔有率。
• 根據應用，預計在預測期內狗的數量將出現最高成長。
• 由於政府對寵物接種疫苗以預防嚴重疾病的嚴格規定以及美國寵物擁有的增加，北美預計仍將是最大的地區。

寵物疫苗市場的策略性成長機會

由於對有效疫苗的需求不斷增加以及對寵物預防性醫療保健的興趣日益濃厚，寵物疫苗市場透過各種應用提供了多種策略性成長機會。以下是按應用程式分類的五個關鍵成長機會：

• 擴大常規免疫計劃：增加常規免疫計劃所涵蓋的疫苗範圍有可能刺激顯著成長。這種方法可確保全面預防多種疾病，並鼓勵更頻繁地去看獸醫，有助於整個寵物疫苗市場的成長。
• 針對異國風寵物的疫苗開發：針對異國風寵物（如爬蟲類和鳥類）的疫苗開發潛力代表著策略性成長機會。市場擴張的動力源於異國風寵物擁有量的不斷增加，以及針對其特定健康需求的疫苗需求的不斷增加。
• 融入寵物健康計劃：將疫苗接種融入綜合寵物健康計劃，透過促進預防性護理提供了策略性成長機會。這些計劃包括定期檢查和接種疫苗，以確保持續照顧您的寵物並減少疾病的發生。
• 增加流動獸醫服務的可用性：流動獸醫服務的可用性，特別是在農村和服務不足的社區，將改善獲得疫苗的機會並創造成長機會。此類服務可以幫助飼主獲得疫苗接種，從而提高疫苗接種水平。
• 寵物和旅遊疫苗接種的成長：隨著越來越多的飼主帶著寵物旅行，對旅遊相關疫苗接種的需求也增加。作為回應，開發和銷售專為旅行寵物設計的疫苗代表著滿足這一群體需求的策略性成長機會。

由於旨在提高疫苗接種率、改善疫苗接種機會和滿足飼主多樣化需求的有針對性的投資，寵物疫苗市場預計將實現顯著成長。

寵物疫苗市場促進因素與挑戰

許多技術、經濟和監管因素影響寵物疫苗市場的成長並帶來挑戰。疫苗的有效性將透過技術進步而提高，可負擔性將受到經濟因素的影響，市場動態將受到監管障礙的影響。因此，了解這些市場促進因素和挑戰對於駕馭市場和確定成長和創新領域至關重要。

推動寵物疫苗市場發展的因素有：

• 寵物主人數量不斷增加：全球寵物主人數量的不斷增加推動了寵物疫苗的需求。隨著越來越多的家庭飼養寵物，對疫苗接種以預防常見疾病的需求也日益成長。這一趨勢正在支持市場擴張並鼓勵開發新的疫苗產品以滿足多樣化的健康需求。
• 疫苗技術的進步：疫苗技術的創新，包括更有效、更安全的配方，是市場成長的主要動力。 mRNA 疫苗和改進的輸送系統等新興技術將提高疫苗的有效性和安全性，擴大市場潛力並應對伴侶動物新出現的健康威脅。
• 提高對寵物健康的認知：飼主對疫苗接種重要性的認知不斷提高，這推動了市場需求。隨著寵物飼主對疫苗接種的好處了解得越來越多，他們將更有可能遵守疫苗接種計劃，從而提高市場滲透率並改善寵物的整體健康狀況。
• 政府和監管支持：政府和監管機構的支持，例如疫苗宣傳活動和津貼，將推動市場成長。這些努力確保疫苗安全、有效、價格合理，進而提高寵物的疫苗接種水準。
• 擴大獸醫服務：擴大獸醫服務，包括新診所和流動單位，將改善寵物接種疫苗的機會。可近性的提高可提高疫苗接種率，擴大市場覆蓋範圍至服務不足的地區，並提供全面的寵物照護。

寵物疫苗市場面臨的挑戰是：

• 疫苗開發成本高：開發和生產疫苗的高成本可能會限制疫苗的可負擔性和可用性。這項挑戰使得低收入寵物飼主難以負擔疫苗接種費用，導致平均寵物擁有率下降，進而影響市場成長。
• 監管障礙：滿足疫苗核准的複雜監管要求將是一項挑戰。這些障礙推遲了新疫苗的推出，增加了開發成本，影響了市場動態，並減緩了創新的步伐。
• 農村地區的認知有限：農村地區對寵物疫苗接種重要性的認知較低可能會阻礙市場的成長。這些地區的低疫苗接種覆蓋率對全面疾病控制構成挑戰並影響整體市場吸收，凸顯了有針對性的教育和推廣活動的必要性。

寵物擁有率上升、疫苗技術的進步以及對寵物健康意識的提高等市場促進因素正在塑造寵物疫苗市場並推動其成長。然而，開發成本高、監管障礙以及農村地區認知度低等挑戰構成了重大障礙。利用市場驅動力和克服挑戰對於推動市場發展和確保廣泛獲得有效的寵物疫苗至關重要。

目錄

第1章執行摘要

第 2 章。

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球寵物疫苗市場趨勢（2019-2024 年）及預測（2025-2031 年）
• 全球寵物疫苗市場類型
  • 犬科動物
  • 貓科
• 全球寵物疫苗市場（按疫苗接種類型）
  • 狗家族
  • 核心疫苗
  • 非核心疫苗
• 全球寵物疫苗市場（依給藥途徑）
  • 注射疫苗
  • 鼻腔內疫苗
• 全球寵物疫苗市場（按應用）
  • 狗
  • 貓
  • 兔子
  • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球寵物疫苗市場（按地區）
• 北美寵物疫苗市場
• 歐洲寵物疫苗市場
• 亞太寵物疫苗市場
• 世界其他地區寵物疫苗市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球寵物疫苗市場成長機會（按類型）
  • 全球寵物疫苗市場成長機會（按疫苗接種類型）
  • 全球寵物疫苗市場按給藥途徑分類的成長機會
  • 全球寵物疫苗市場成長機會（按應用）
  • 全球寵物疫苗市場各區域成長機會
• 全球寵物疫苗市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球寵物疫苗市場產能擴張
  • 全球寵物疫苗市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

The future of the global pet vaccine market looks promising with opportunities in the dog, cat, and rabbit applications. The global pet vaccine market is expected to reach an estimated $11.2 billion by 2031 with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet animals, growing awareness among pet owners about the benefits of preventive healthcare for their pets, and government regulations regarding vaccinations.

• Lucintel forecasts that, within the vaccination category, the canine family will remain the largest segment due to the rising popularity of companion animals, growing awareness of the importance of animal health, and the evolving lifestyles of pet owners.
• Within the application category, dog is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccinations to protect pets from serious diseases and the rising adoption of pets in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Pet Vaccine Market

Emerging trends are reshaping the future of the pet vaccine market as it undergoes significant transformation. Developments in pet ownership patterns, technological innovations, and the increasing focus on preventive healthcare have been key drivers of these trends. The following are five major trends that are influencing the pet vaccine market.

• Personalized Pet Vaccination Plans: Personalized pet vaccination plans have become a popular trend among veterinarians who now offer customized vaccination schedules based on individual pet needs. This approach ensures that vaccines given to pets are appropriate, thereby reducing instances of over-vaccination and improving the overall health of pets. With personalized plans becoming increasingly common, pet owners looking for tailored care for their animals represent yet another example of this wider tendency toward humanizing these companions.
• Growth of Combination Vaccines: In the pet vaccine market, there is increased usage of combination vaccines, which protect against multiple diseases through a single shot. These vaccines save time and reduce anxiety levels for both pets and people because fewer vet visits are needed. Cost-effectiveness, along with rising awareness about overall wellness for pets, has led to increased demand for combination vaccines compared with other types available in many areas.
• Advances in Vaccine Technology: There is development of new vaccine formulations, including DNA and mRNA vaccines, aimed at providing better protection with reduced side effects within the pet vaccine market due to technological advancements in vaccine development. They would result in more effective vaccines that can be manufactured and delivered more efficiently to satisfy the growing global demand for high-quality pet vaccines.
• Increased Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare in the pet vaccine market, with regular vaccinations becoming increasingly important as part of routine care by pet owners. This trend is supported by veterinary professionals who advocate for proactive health management to prevent disease onset. As preventive care becomes mainstream, it will likely boost the demand for vaccinations and related health services.
• Expansion of Veterinary Services: Opening new clinics and mobile veterinary units plays a major role in expanding access to pet vaccines, especially in rural and underserved regions. The result of this trend is that vaccination rates have increased, leading to improved overall health among pets. Veterinary services will likely be pivotal in supporting the growth of the pet vaccine market as it continues to expand.

These emerging trends are reshaping the pet vaccine market by driving innovation, enhancing access to vaccines, and improving the overall standard of pet healthcare. As these trends continue to evolve, they will contribute to a more robust and dynamic market, better equipped to meet the needs of pet owners and their animals.

Recent Developments in the Pet Vaccine Market

The market for pet vaccines has undergone several developments that improve vaccine effectiveness, accessibility, and adoption. These improvements are crucial in responding to the increasing need for comprehensive pet healthcare. Below are five key developments that are significantly influencing the market.

• Introduction of Modern Vaccines: Recent developments include the introduction of modern vaccines that offer immunity against targeted diseases and have limited side effects. The new vaccines help protect against newly emerging infections among animals, raising vaccination rates and leading to better health outcomes among pets.
• Expansion of Global Vaccine Manufacturing: The expansion of global vaccine manufacturing capabilities is improving supply chain efficiency and accessibility of vaccines in different regions. This is vital since it helps meet the demand for pet vaccines in new markets by ensuring the continued supply of quality vaccines.
• Regulatory Approvals for New Vaccines: Regulatory authorities in some countries have approved specific pet vaccines related to novel diseases, reflecting the increasing emphasis on preventing diseases rather than curing them after they attack pets. This allows more specialized vaccines to be introduced, covering various needs of pets in different locations.
• Growth in Pet Insurance Coverage: The growth of pet insurance coverage, including vaccination costs, encourages more pet owners to vaccinate their pets. Higher vaccination rates and a wider range of vaccine requirements drive growth within the overall pet vaccine market.
• Collaboration Between Veterinary Professionals and Pharma Companies: Collaboration between veterinary professionals and pharmaceutical firms results in stronger vaccine development as well as improved vaccination protocols. Such alliances play an important role in promoting innovation and adapting vaccines according to the changing needs experienced by domestic animals and their owners.

These recent advancements significantly impact the pet vaccine market through improved efficiency and increased access levels, while accelerating the adoption rate. Generally, all these changes favor a more flexible pet vaccine industry that can address health issues affecting animals worldwide.

Strategic Growth Opportunities for Pet Vaccine Market

The pet vaccine market provides several strategic growth opportunities throughout various applications, driven by increasing demand for effective vaccines and a growing focus on preventive pet healthcare. Here are five major growth opportunities by application.

• Expanding Routine Vaccination Programs: Broadening the range of vaccines covered under routine vaccination programs has the potential to spur significant growth. This approach ensures comprehensive protection from multiple diseases and stimulates frequent visits to vets, thereby supporting overall pet vaccine market expansion.
• Developing Specialized Vaccines for Exotic Pets: The possibility of developing vaccines specifically for exotic pets, like reptiles and birds, represents a strategic growth opportunity. Market expansion is driven by the increasing ownership of exotic pets, while the demand for their specific health needs rises for vaccines.
• Integration with Pet Wellness Programs: Incorporating vaccines into comprehensive pet wellness programs provides a strategic growth opportunity through the promotion of preventive care. These programs include regular check-ups and vaccinations, guaranteeing consistent care for pets and reducing disease outbreaks.
• Increasing Availability of Mobile Veterinary Services: The availability of mobile veterinary services, particularly in rural areas or underserved communities, can enhance access to vaccines, creating an opportunity for growth. These services reach pet owners who cannot easily find traditional veterinary clinics, thus increasing vaccination levels.
• Growth in Pet Travel Vaccinations: The number of pet owners traveling with their animals has increased, resulting in increased demand for travel-related vaccinations. In response, developing and marketing vaccines specifically designed for traveling pets presents a strategic growth opportunity that serves the needs of this population.

The pet vaccine market is poised for significant growth acceleration due to targeted investments aimed at boosting vaccine coverage, improving access, and meeting the varied requirements of pet owners.

Pet Vaccine Market Driver and Challenges

Numerous technological, economic, and regulatory factors influence the growth of the pet vaccine market and present challenges. Vaccine efficacy is improved by technological advancements; affordability is affected by economic factors, and market dynamics are shaped by regulatory obstacles. Thus, understanding these drivers and challenges is critical to successfully navigating the market and identifying areas for growth and innovation.

The factors driving the pet vaccine market include:

• Rising Pet Ownership: The increasing number of pet owners globally drives demand for pet vaccines. As more households adopt pets, the need for vaccines to prevent common diseases grows. This trend supports market expansion and encourages the development of new vaccine products to address diverse health needs.
• Advances in Vaccine Technology: Innovations in vaccine technology, including more effective and safer formulations, are significant drivers of market growth. Advanced technologies, such as mRNA vaccines and improved delivery systems, enhance vaccine efficacy and safety, expanding market potential and addressing emerging health threats in pets.
• Growing Awareness of Pet Health: Increased awareness among pet owners about the importance of vaccinations drives market demand. As pet owners become more informed about the benefits of vaccines, they are more likely to adhere to vaccination schedules, leading to higher market adoption rates and better overall pet health.
• Government and Regulatory Support: Support from governments and regulatory bodies, including vaccination campaigns and subsidies, promotes market growth. These initiatives ensure vaccine safety and efficacy, making them accessible at reasonable prices and thereby raising vaccination levels among pets.
• Expansion of Veterinary Services: The growth of veterinary services, including new clinics and mobile units, enhances access to pet vaccines. Improved accessibility leads to higher vaccination rates, supporting market expansion to reach underserved areas and providing comprehensive pet healthcare.

Challenges in the pet vaccine market include:

• High Cost of Vaccine Development: The high cost associated with developing and producing vaccines can limit affordability and accessibility. This challenge affects market growth by making it difficult for low-income pet owners to afford them, resulting in a decrease in average ownership rates.
• Regulatory Hurdles: Navigating complex regulatory requirements for vaccine approval poses a challenge. These hurdles can delay the introduction of new vaccines and increase development costs, affecting market dynamics and slowing the pace of innovation.
• Limited Awareness in Rural Areas: Limited awareness about the importance of pet vaccinations in rural areas can hinder market growth. Low vaccination rates in these regions challenge comprehensive disease control and impact overall market adoption, highlighting the need for targeted education and outreach efforts.

Drivers such as rising pet ownership, advances in vaccine technology, and increased awareness of pet health shape the pet vaccine market and promote its growth. Nonetheless, challenges like high development costs, regulatory hurdles, and limited awareness in rural areas are substantial barriers. Addressing these challenges while leveraging growth drivers will be essential for advancing the market and ensuring broader access to effective pet vaccines.

List of Pet Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pet vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pet vaccine companies profiled in this report include-

• Elanco
• Merck
• Ceva
• Virbac
• Zoetis
• HIPRA
• Merial

Pet Vaccine by Segment

The study includes a forecast for the global pet vaccine market by type, vaccination, mode of administration, application, and region.

Pet Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Canlane
• Feline

Pet Vaccine Market by Vaccination [Analysis by Value from 2019 to 2031]:

• Canine Family
• Core Vaccines
• Non-Core Vaccines

Pet Vaccine Market by Mode of Administration [Analysis by Value from 2019 to 2031]:

• Injectable Vaccines
• Intranasal Vaccines

Pet Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Dogs
• Cats
• Rabbits
• Others

Pet Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pet Vaccine Market

The global market for pet vaccines has seen major developments in different regions due to the rise of pet ownership, awareness of pet health, and innovations made in vaccine technology. These changes help to meet the increasing need for effective vaccines that ensure pets are healthy worldwide. Here are some of the most important developments in the pet vaccine market across the United States, China, Germany, India, and Japan.

• USA: The US pet vaccine market has seen a remarkable upswing due to the emerging trend of anthropomorphism regarding pets. Recent developments include the launch of advanced vaccines that target emerging pet diseases and an increased number of veterinary practices providing custom vaccination plans. Furthermore, partnerships between biotech corporations and schools have resulted in better vaccine formulations, making pet vaccines more effective and secure.
• China: The Chinese pet vaccine market is growing rapidly as the urban population continues to adopt pets. Additionally, new regulations concerning vaccinations have been implemented by the government, propelling growth in this industry. Key highlights include the authorization of new domestically manufactured vaccines and partnerships between local firms and international companies aimed at improving quality and distribution systems, leading to an increasing demand for pet healthcare products.
• Germany: Germany's pet vaccine market thrives on research and development. Recent developments include the introduction of vaccines targeting exotic pets and an increased emphasis on preventive care measures. Moreover, significant investment has been made toward creating a robust animal health infrastructure; for example, there has been an expansion of veterinary clinics and specialist pet hospitals, allowing larger numbers to be vaccinated against various disease-causing agents and maintaining better overall health among animals.
• India: Rising middle-class households adopting pets, together with increasing awareness about pet health, have spurred growth within India's pet vaccine marketplace. Developments here include low-cost vaccine alternatives focusing on common ailments affecting domestic animals, combined with government initiatives aimed at creating awareness about available options for protecting pets against diseases through vaccination campaigns. Additionally, the entry of global veterinary pharmaceutical companies into the Indian market has increased the reliable supply of good-quality vaccines.
• Japan: The Japanese pet vaccine market is characterized by an increasing embrace of advanced vaccine techniques and personalized pet healthcare. Recent developments include the adoption of new vaccine delivery systems, such as oral vaccines that simplify administration. In addition, there has been a growing trend for pet wellness programs with comprehensive vaccination plans, indicating an appreciation of preventive healthcare among pet owners.

Features of the Global Pet Vaccine Market

Market Size Estimates: Pet vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Pet vaccine market size by various segments, such as by type, vaccination, mode of administration, application, and region in terms of ($B).

Regional Analysis: Pet vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, vaccinations, mode of administrations, applications, and regions for the pet vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pet vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pet vaccine market by type (canlane and feline), vaccination (canine family, core vaccines, and non-core vaccines), mode of administration (injectable vaccines and intranasal vaccines), application (dogs, cats, rabbits, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pet Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Pet Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Pet Vaccine Market by Type
  • 3.3.1: Canlane
  • 3.3.2: Feline
• 3.4: Global Pet Vaccine Market by Vaccination
  • 3.4.1: Canine Family
  • 3.4.2: Core Vaccines
  • 3.4.3: Non-Core Vaccines
• 3.5: Global Pet Vaccine Market by Mode of Administration
  • 3.5.1: Injectable Vaccines
  • 3.5.2: Intranasal Vaccines
• 3.6: Global Pet Vaccine Market by Application
  • 3.6.1: Dogs
  • 3.6.2: Cats
  • 3.6.3: Rabbits
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Pet Vaccine Market by Region
• 4.2: North American Pet Vaccine Market
  • 4.2.1: North American Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.2.2: North American Market by Application: Dogs, Cats, Rabbits, and Others
• 4.3: European Pet Vaccine Market
  • 4.3.1: European Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.3.2: European Market by Application: Dogs, Cats, Rabbits, and Others
• 4.4: APAC Pet Vaccine Market
  • 4.4.1: APAC Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.4.2: APAC Market by Application: Dogs, Cats, Rabbits, and Others
• 4.5: ROW Pet Vaccine Market
  • 4.5.1: ROW Market by Vaccination: Canine Family, Core Vaccines, and Non-Core Vaccines
  • 4.5.2: ROW Market by Application: Dogs, Cats, Rabbits, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pet Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pet Vaccine Market by Vaccination
  • 6.1.3: Growth Opportunities for the Global Pet Vaccine Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Pet Vaccine Market by Application
  • 6.1.5: Growth Opportunities for the Global Pet Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pet Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pet Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pet Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco
• 7.2: Merck
• 7.3: Ceva
• 7.4: Virbac
• 7.5: Zoetis
• 7.6: HIPRA
• 7.7: Merial